Navigasjon

  • Hopp til innhold
NTNU Hjemmeside NTNU Hjemmeside

ntnu.no

  • Studier
    • Studere på NTNU
    • Finn studieprogram
    • Søke opptak
    • Videreutdanning og deltid
    • Forkurs og oppfriskning
  • Studentliv
    • Student i Gjøvik
    • Student i Trondheim
    • Student i Ålesund
  • Forskning og innovasjon
    • Forskning
    • Innovasjon
    • Satsingsområder
    • Toppforskning
    • Ekspertlister
    • Ph.d.
  • Om NTNU
    • Fakulteter og institutter
    • Sentre
    • Bibliotek
    • Kart
    • Ledige stillinger
    • Arrangement
    • Nyheter
    • Kontakt oss
    • Om NTNU
  1. Ansatte

Språkvelger

English

Magne Børset

Last ned pressefoto
Last ned pressefoto
Foto:

Magne Børset

Professor
Institutt for klinisk og molekylær medisin

magne.borset@ntnu.no
91194488 72573038 Gastrosenteret, 433.03.008, Øya, Prinsesse Kristinas gate 1
Scopus Author ID: 7004270092
Om Publikasjoner

Om

CV

Fagenhet: Translasjonell kreftforskning. Forskergruppetilhørighet: Klinisk-akademisk gruppe for myelomatoseforskning.

I forskningen min studerer jeg egenskaper hos kreftceller fra pasienter med myelomatose, kreft i beinmargen. Kreftcellene hos pasienter med myelomatose overlever i beinmargen på grunn av stimulerende signaler fra mikromiljøet der. Jeg studerer effekten av slike signaler på kreftcellene. Målet er å finne angrepspunkt for framtidig behandling av myelomatose. Dersom vi kunne finne medikamenter som avskjærer signaler som er livsviktige for kreftcellene, ville vi potensielt kunne bruke dem til å helbrede pasientene. Vi har blant annet funnet at vekstfaktorer i beinmargen skrur på genene for enzymene PRL-3 og SGK-1 i kreftcellene. Forskningen vår viser at dette er enzymer som har betydning for overlevelse og vekst av cellene og vi arbeider for å kartlegge mer fullstendig den rollen som disse enzymene har.

Vi har bl.a. vist at PRL-3 påvirker stoffskiftet i kreftcellene til å utvinne energi fra glukose uten å forbruke oksygen. Det gjør det lettere for dem å leve i omgivelser med lav oksygenmetning. 

Publikasjoner

  • Kronologisk
  • Etter kategori
  • Se alle publikasjoner i Cristin

2016

  • Våtsveen, Thea Kristin; Børset, Magne; Dikic, Aida; Tian, Erming; Micci, Francesca; Lid, Ana Barragan. (2016) VOLIN and KJON—Two novel hyperdiploid myeloma cell lines. Genes, Chromosomes and Cancer
    Vitenskapelig artikkel
  • Abdollahi, Pegah; Vandsemb, Esten Nymoen; Hjort, Magnus Aassved; Misund, Kristine; Holien, Toril; Sponaas, Anne-Marit. (2016) Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3. Molecular Cancer Research
    Vitenskapelig artikkel
  • Slørdahl, Tobias Schmidt; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Rampa, Christoph Samuel; Misund, Kristine; Baranowska, Katarzyna Anna. (2016) The phosphatase of regenerating liver-3 (PRL-3) is importantfor IL-6-mediated survival of myeloma cells. OncoTarget
    Vitenskapelig artikkel

2013

  • Slørdahl, Tobias Schmidt; Denayer, Tinneke; Moen, Siv Helen; Standal, Therese; Børset, Magne; Ververken, Cedric. (2013) Anti-c-MET Nanobody® – a new potential drug in multiple myeloma treatment. European Journal of Haematology
    Vitenskapelig artikkel
  • Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders. (2013) HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology
    Vitenskapelig artikkel

2012

  • Holien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Rampa, Christoph Samuel; Brede, Gaute; Grøseth, Lill Anny Gunnes. (2012) Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia
    Vitenskapelig artikkel
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders. (2012) Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology
    Vitenskapelig artikkel

2011

  • Skliris, A; Happonen, KE; Terpos, Evangelos; Labropoulou, V; Børset, Magne; Heinegård, Dick. (2011) Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma. European Journal of Immunology
    Vitenskapelig artikkel
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders. (2011) Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology
    Vitenskapelig artikkel
  • Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne. (2011) Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene
    Vitenskapelig artikkel

2009

  • Vatsveen, TK; Våtsveen, Thea Kristin; Tian, Erming; Kresse, Stine H; Meza-Zepada, Leonardo; Meza, Leonardo Zepeda. (2009) OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus. Leukemia Research
    Vitenskapelig artikkel
  • Våtsveen, Thea Kristin; Brenne, Anne-Tove; Dai, HY; Waage, Anders; Sundan, Anders; Børset, Magne. (2009) FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14). European Journal of Haematology
    Vitenskapelig artikkel

2008

  • Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Thea Kristin; Zhan, FH; Egeberg, Kjartan Wøllo. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
    Vitenskapelig oversiktsartikkel/review

2007

  • Holt, RU; Fagerli, UM; Ro, TB; Baykov, V; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
    Sammendrag/abstract

2006

  • Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne. (2006) HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood
    Sammendrag/abstract
  • Bohnhorst, Janne Øvrebø; Rasmussen, T; Moen, Siv H; Fløttum, Marianne; Knudsen, L; Børset, Magne. (2006) Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia
    Vitenskapelig artikkel

2005

  • Holt, Randi Utne; Baykov, Vadim; Rø, Torstein Baade; Brabrand, Sigmund; Waage, Anders; Sundan, Anders. (2005) Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor. Haematologica
    Vitenskapelig artikkel

2004

  • Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
    Vitenskapelig artikkel
  • Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. (2004) Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene
    Vitenskapelig artikkel

2002

  • Standal, Therese; Børset, Magne; Lenhoff, S.; Wisløff, Finn; Størdal, Berit Fladval; Sundan, Anders. (2002) Serum insulin-like growth factor is not increased in patients with multiple myelomna but is still a prognostic factor. Blood
    Vitenskapelig artikkel
  • Brenne, Anne Tove; Rø, Torstein Baade; Waage, Anders; Sundan, Anders; Børset, Magne; Hjorth-Hansen, Henrik. (2002) Interleukin-21 is a growth and survival factor for human myeloma cells. Blood
    Vitenskapelig artikkel

2001

  • Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan. (2001) Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood
    Vitenskapelig artikkel
  • Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood
    Vitenskapelig artikkel
  • Feuerherm, Astrid; Børset, Magne; Seidel, Carina; Sundan, Anders; Leistad, Lilian; Østensen, Monica. (2001) Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scandinavian Journal of Rheumatology
    Vitenskapelig artikkel

2000

  • Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D.. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood
    Vitenskapelig artikkel
  • Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik. (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood
    Vitenskapelig artikkel
  • Seidel, Carina; Sundan, Anders; Hjorth, Martin; Turesson, Ingemar; Dahl, Inger Marie S.; Abildgaard, Niels. (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood
    Vitenskapelig artikkel

1999

  • Børset, Magne; Hjort-Hansen, Henrik; Johnsen, Ann-Charlotte; Seidel, Carina; Waage, Anders; Espevik, Terje. (1999) Apoptosis, proliferation and NF-k(kappa)B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. European Journal of Haematology
    Vitenskapelig artikkel
  • Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood
    Vitenskapelig artikkel
  • Hjort-Hansen, Henrik; Waage, Anders; Børset, M.. (1999) Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. British Journal of Haematology
    Vitenskapelig artikkel
  • Hjorth-Hansen, H.; Seifert, MF.; Børset, M.; Aarset, H.; Ostlie, A.; Sundan, A.. (1999) Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. Journal of Bone and Mineral Research
    Vitenskapelig artikkel

1998

  • Seidel, C; Børset, M; Turesson, I; Abilgaard, N; Sundan, A.; Waage, Anders. (1998) Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood
    Vitenskapelig artikkel

1996

  • Børset, Magne; Medvedev, Andrei E.; Sundan, Anders; Espevik, Terje. (1996) The role of the two TNF receptors in proliferation, NF-_KB activation and discrimination between TNF and LT_a signalling in the human myeloma cell line OH-2. Cytokine
    Vitenskapelig artikkel
  • Børset, Magne; Lien, Egil; Espevik, Terje; Helseth, Eirik; Waage, Anders; Sundan, Anders. (1996) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. Journal of Biological Chemistry
    Vitenskapelig artikkel
  • Børset, Magne; Hjorth-Hansen, Henrik; Seidel, Carina; Sundan, Anders; Waage, Anders. (1996) Hepatocyte growth factor and its receptor c-MET in multiple myeloma. Blood
    Vitenskapelig artikkel

Tidsskriftspublikasjoner

  • Våtsveen, Thea Kristin; Børset, Magne; Dikic, Aida; Tian, Erming; Micci, Francesca; Lid, Ana Barragan. (2016) VOLIN and KJON—Two novel hyperdiploid myeloma cell lines. Genes, Chromosomes and Cancer
    Vitenskapelig artikkel
  • Abdollahi, Pegah; Vandsemb, Esten Nymoen; Hjort, Magnus Aassved; Misund, Kristine; Holien, Toril; Sponaas, Anne-Marit. (2016) Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3. Molecular Cancer Research
    Vitenskapelig artikkel
  • Slørdahl, Tobias Schmidt; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Rampa, Christoph Samuel; Misund, Kristine; Baranowska, Katarzyna Anna. (2016) The phosphatase of regenerating liver-3 (PRL-3) is importantfor IL-6-mediated survival of myeloma cells. OncoTarget
    Vitenskapelig artikkel
  • Slørdahl, Tobias Schmidt; Denayer, Tinneke; Moen, Siv Helen; Standal, Therese; Børset, Magne; Ververken, Cedric. (2013) Anti-c-MET Nanobody® – a new potential drug in multiple myeloma treatment. European Journal of Haematology
    Vitenskapelig artikkel
  • Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders. (2013) HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology
    Vitenskapelig artikkel
  • Holien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Rampa, Christoph Samuel; Brede, Gaute; Grøseth, Lill Anny Gunnes. (2012) Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia
    Vitenskapelig artikkel
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders. (2012) Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology
    Vitenskapelig artikkel
  • Skliris, A; Happonen, KE; Terpos, Evangelos; Labropoulou, V; Børset, Magne; Heinegård, Dick. (2011) Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma. European Journal of Immunology
    Vitenskapelig artikkel
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders. (2011) Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology
    Vitenskapelig artikkel
  • Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne. (2011) Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene
    Vitenskapelig artikkel
  • Vatsveen, TK; Våtsveen, Thea Kristin; Tian, Erming; Kresse, Stine H; Meza-Zepada, Leonardo; Meza, Leonardo Zepeda. (2009) OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus. Leukemia Research
    Vitenskapelig artikkel
  • Våtsveen, Thea Kristin; Brenne, Anne-Tove; Dai, HY; Waage, Anders; Sundan, Anders; Børset, Magne. (2009) FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14). European Journal of Haematology
    Vitenskapelig artikkel
  • Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Thea Kristin; Zhan, FH; Egeberg, Kjartan Wøllo. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
    Vitenskapelig oversiktsartikkel/review
  • Holt, RU; Fagerli, UM; Ro, TB; Baykov, V; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
    Sammendrag/abstract
  • Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne. (2006) HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood
    Sammendrag/abstract
  • Bohnhorst, Janne Øvrebø; Rasmussen, T; Moen, Siv H; Fløttum, Marianne; Knudsen, L; Børset, Magne. (2006) Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia
    Vitenskapelig artikkel
  • Holt, Randi Utne; Baykov, Vadim; Rø, Torstein Baade; Brabrand, Sigmund; Waage, Anders; Sundan, Anders. (2005) Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor. Haematologica
    Vitenskapelig artikkel
  • Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
    Vitenskapelig artikkel
  • Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. (2004) Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene
    Vitenskapelig artikkel
  • Standal, Therese; Børset, Magne; Lenhoff, S.; Wisløff, Finn; Størdal, Berit Fladval; Sundan, Anders. (2002) Serum insulin-like growth factor is not increased in patients with multiple myelomna but is still a prognostic factor. Blood
    Vitenskapelig artikkel
  • Brenne, Anne Tove; Rø, Torstein Baade; Waage, Anders; Sundan, Anders; Børset, Magne; Hjorth-Hansen, Henrik. (2002) Interleukin-21 is a growth and survival factor for human myeloma cells. Blood
    Vitenskapelig artikkel
  • Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan. (2001) Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood
    Vitenskapelig artikkel
  • Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood
    Vitenskapelig artikkel
  • Feuerherm, Astrid; Børset, Magne; Seidel, Carina; Sundan, Anders; Leistad, Lilian; Østensen, Monica. (2001) Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scandinavian Journal of Rheumatology
    Vitenskapelig artikkel
  • Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D.. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood
    Vitenskapelig artikkel
  • Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik. (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood
    Vitenskapelig artikkel
  • Seidel, Carina; Sundan, Anders; Hjorth, Martin; Turesson, Ingemar; Dahl, Inger Marie S.; Abildgaard, Niels. (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood
    Vitenskapelig artikkel
  • Børset, Magne; Hjort-Hansen, Henrik; Johnsen, Ann-Charlotte; Seidel, Carina; Waage, Anders; Espevik, Terje. (1999) Apoptosis, proliferation and NF-k(kappa)B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. European Journal of Haematology
    Vitenskapelig artikkel
  • Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood
    Vitenskapelig artikkel
  • Hjort-Hansen, Henrik; Waage, Anders; Børset, M.. (1999) Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. British Journal of Haematology
    Vitenskapelig artikkel
  • Hjorth-Hansen, H.; Seifert, MF.; Børset, M.; Aarset, H.; Ostlie, A.; Sundan, A.. (1999) Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. Journal of Bone and Mineral Research
    Vitenskapelig artikkel
  • Seidel, C; Børset, M; Turesson, I; Abilgaard, N; Sundan, A.; Waage, Anders. (1998) Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood
    Vitenskapelig artikkel
  • Børset, Magne; Medvedev, Andrei E.; Sundan, Anders; Espevik, Terje. (1996) The role of the two TNF receptors in proliferation, NF-_KB activation and discrimination between TNF and LT_a signalling in the human myeloma cell line OH-2. Cytokine
    Vitenskapelig artikkel
  • Børset, Magne; Lien, Egil; Espevik, Terje; Helseth, Eirik; Waage, Anders; Sundan, Anders. (1996) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. Journal of Biological Chemistry
    Vitenskapelig artikkel
  • Børset, Magne; Hjorth-Hansen, Henrik; Seidel, Carina; Sundan, Anders; Waage, Anders. (1996) Hepatocyte growth factor and its receptor c-MET in multiple myeloma. Blood
    Vitenskapelig artikkel

NTNU – Norges teknisk-naturvitenskapelige universitet

  • For ansatte
  • |
  • For studenter
  • |
  • Innsida
  • |
  • Blackboard

Studere

  • Om studier
  • Studieprogram
  • Emner
  • Videreutdanning
  • Karriere

Aktuelt

  • Nyheter
  • Arrangement
  • Jobbe ved NTNU

Om NTNU

  • Om NTNU
  • Bibliotek
  • Strategi
  • Forskning
  • Satsingsområder
  • Innovasjon
  • Organisasjonskart
  • Utdanningskvalitet

Kontakt

  • Kontakt oss
  • Finn ansatte
  • Spør en ekspert
  • Pressekontakter
  • Kart

NTNU i tre byer

  • NTNU i Gjøvik
  • NTNU i Trondheim
  • NTNU i Ålesund

Om nettstedet

  • Bruk av informasjonskapsler
  • Tilgjengelighetserklæring
  • Personvern
  • Ansvarlig redaktør
Facebook Instagram Linkedin Snapchat Tiktok Youtube
Logg inn
NTNU logo